These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 22536837

  • 1. Testosterone replacement therapy outcomes among opioid users: the Testim Registry in the United States (TRiUS).
    Blick G, Khera M, Bhattacharya RK, Nguyen D, Kushner H, Miner MM.
    Pain Med; 2012 May; 13(5):688-98. PubMed ID: 22536837
    [Abstract] [Full Text] [Related]

  • 2. Changes in prostate specific antigen in hypogonadal men after 12 months of testosterone replacement therapy: support for the prostate saturation theory.
    Khera M, Bhattacharya RK, Blick G, Kushner H, Nguyen D, Miner MM.
    J Urol; 2011 Sep; 186(3):1005-11. PubMed ID: 21788049
    [Abstract] [Full Text] [Related]

  • 3. 12-month observation of testosterone replacement effectiveness in a general population of men.
    Miner MM, Bhattacharya RK, Blick G, Kushner H, Khera M.
    Postgrad Med; 2013 Mar; 125(2):8-18. PubMed ID: 23816767
    [Abstract] [Full Text] [Related]

  • 4. Testosterone replacement therapy in men with hypogonadism and HIV/AIDS: results from the TRiUS registry.
    Blick G, Khera M, Bhattacharya RK, Kushner H, Miner MM.
    Postgrad Med; 2013 Mar; 125(2):19-29. PubMed ID: 23816768
    [Abstract] [Full Text] [Related]

  • 5. Improved sexual function with testosterone replacement therapy in hypogonadal men: real-world data from the Testim Registry in the United States (TRiUS).
    Khera M, Bhattacharya RK, Blick G, Kushner H, Nguyen D, Miner MM.
    J Sex Med; 2011 Nov; 8(11):3204-13. PubMed ID: 21834870
    [Abstract] [Full Text] [Related]

  • 6. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
    Blick G.
    Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
    [Abstract] [Full Text] [Related]

  • 7. Testosterone replacement therapy among elderly males: the Testim Registry in the US (TRiUS).
    Bhattacharya RK, Khera M, Blick G, Kushner H, Miner MM.
    Clin Interv Aging; 2012 Mar; 7():321-30. PubMed ID: 22956867
    [Abstract] [Full Text] [Related]

  • 8. The effect of testosterone supplementation on depression symptoms in hypogonadal men from the Testim Registry in the US (TRiUS).
    Khera M, Bhattacharya RK, Blick G, Kushner H, Nguyen D, Miner MM.
    Aging Male; 2012 Mar; 15(1):14-21. PubMed ID: 22092151
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men.
    Grober ED, Khera M, Soni SD, Espinoza MG, Lipshultz LI.
    Int J Impot Res; 2008 Mar; 20(2):213-7. PubMed ID: 17898800
    [Abstract] [Full Text] [Related]

  • 10. Testim 1% testosterone gel for the treatment of male hypogonadism.
    Bouloux P.
    Clin Ther; 2005 Mar; 27(3):286-98. PubMed ID: 15878382
    [Abstract] [Full Text] [Related]

  • 11. Serum adiponectin levels in hypogonadal males: influence of testosterone replacement therapy.
    Lanfranco F, Zitzmann M, Simoni M, Nieschlag E.
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):500-7. PubMed ID: 15049966
    [Abstract] [Full Text] [Related]

  • 12. Baseline data from the TRiUS registry: symptoms and comorbidities of testosterone deficiency.
    Miner MM, Khera M, Bhattacharya RK, Blick G, Kushner H.
    Postgrad Med; 2011 May; 123(3):17-27. PubMed ID: 21566412
    [Abstract] [Full Text] [Related]

  • 13. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
    Coward RM, Simhan J, Carson CC.
    BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
    [Abstract] [Full Text] [Related]

  • 14. Transdermal testosterone gel increases serum testosterone levels in hypogonadal men in Taiwan with improvements in sexual function.
    Chiang HS, Hwang TI, Hsui YS, Lin YC, Chen HE, Chen GC, Liao CH.
    Int J Impot Res; 2007 May; 19(4):411-7. PubMed ID: 17538639
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A small-scale clinical trial to determine the safety and efficacy of testosterone replacement therapy in hypogonadal men with spinal cord injury.
    Bauman WA, Cirnigliaro CM, La Fountaine MF, Jensen AM, Wecht JM, Kirshblum SC, Spungen AM.
    Horm Metab Res; 2011 Jul; 43(8):574-9. PubMed ID: 21717386
    [Abstract] [Full Text] [Related]

  • 17. Prostate-specific antigen (PSA) concentrations in hypogonadal men during 6 years of transdermal testosterone treatment.
    Raynaud JP, Gardette J, Rollet J, Legros JJ.
    BJU Int; 2013 May; 111(6):880-90. PubMed ID: 23294726
    [Abstract] [Full Text] [Related]

  • 18. Review of Testim gel.
    McNicholas T, Ong T.
    Expert Opin Pharmacother; 2006 Mar; 7(4):477-84. PubMed ID: 16503819
    [Abstract] [Full Text] [Related]

  • 19. Registry of Hypogonadism in Men (RHYME): design of a multi-national longitudinal, observational registry of exogenous testosterone use in hypogonadal men.
    Rosen RC, Wu FC, Behre HM, Roehrborn CG, Schröder FH, Siami FS, Martha JF, Finn JD, Araujo AB.
    Aging Male; 2013 Mar; 16(1):1-7. PubMed ID: 23373674
    [Abstract] [Full Text] [Related]

  • 20. A long-term, prospective study of the physiologic and behavioral effects of hormone replacement in untreated hypogonadal men.
    Burris AS, Banks SM, Carter CS, Davidson JM, Sherins RJ.
    J Androl; 1992 Mar; 13(4):297-304. PubMed ID: 1399830
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.